Wantai Bio senior executive completes share reduction plan
Beijing Wantai Biological Pharmacy Enterprise (SSE:603392) announced today that Deputy General Manager Ye Xiangzhong has completed the planned reduction of his company shares. According to the announcement, Ye Xiangzhong sold 99,300 shares between March 6, 2025, and May 28, 2025, through centralized bidding at an average price of CNY68.61 per share, for a total of CNY6,812,507. Following the transaction, Ye Xiangzhong's holdings in Wantai Bio decreased from 462,079 shares (0.0365% of the total share capital) to 362,779 shares (0.0287% of the total share capital). The share reduction plan was consistent with previous disclosures.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Beijing Wantai Biological Pharmacy Enterprise publishes news
Free account required • Unsubscribe anytime